Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 32,462 | 24,792 | 24,458 | 22,204 | 22,204 |
| Operating Income | -32,462 | -24,792 | -24,458 | -22,204 | -22,204 |
| Interest Expense | 656 | 727 | 466 | 434 | 439 |
| Other Income | -1,623 | 11,835 | 19,070 | -31,762 | -1,221 |
| Pre-tax Income | -34,741 | -13,684 | -5,854 | -54,400 | -23,864 |
| Net Income Continuous | -34,741 | -13,684 | -5,854 | -54,400 | -23,864 |
| Net Income | $-34,741 | $-13,684 | $-5,854 | $-54,400 | $-23,864 |
| EPS Basic Total Ops | -0.14 | -0.18 | -0.08 | -1.14 | -0.58 |
| EPS Basic Continuous Ops | -0.15 | -0.18 | -0.08 | -1.14 | -0.59 |
| EPS Diluted Total Ops | 0.13 | -0.27 | -0.26 | -1.14 | -0.58 |
| EPS Diluted Continuous Ops | -0.16 | -0.17 | -0.08 | -1.14 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.41 | -0.27 | -0.48 | N/A | N/A |
| EBITDA(a) | $-32,462 | $-24,792 | $-24,458 | $-21,677 | $-21,313 |